Directions: All incidents (minor issues, protocol change/deviation, unanticipated problems, or adverse events) must be reported by the principal investigator/project evaluator/researcher directly to HIRB within 10 calendar days from the date of discovery. In addition, for more severe problems or events, the project sponsor or funding agency must also be notified. For more information on incident reporting, the FDA has a guidance document that can be accessed at
http://www.fda.gov/downlaods/RegulatoryInformation/Guidances/UCM126572.pdf